TRVI (TRVI) Stock Price & Analysis
TRVI (TRVI) rose 1.17% to USD 17.26 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.
TRVI last closed at USD 17.26; the session ranged USD 16.8–17.32 on volume of 856,672 shares. Market capitalization is —, with a 52-week range of USD 7.44–20.22 (NGM). Source: Nexqual, September 8, 2026 at 06:23 UTC.
Key Statistics (as of September 8, 2026 at 06:23 UTC)
| Price | USD 17.26 |
|---|---|
| Change | ▲ 1.17% (up) |
| Previous Close | USD 17.26 |
| Open | USD 17.26 |
| Day Range | USD 16.8 – 17.32 |
| 52-Week Range | USD 7.44 – 20.22 |
| Volume | 856,672 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (TRVI)
Nexqual's technical model rates TRVI "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.64 (neutral) |
| vs SMA50 | Below (USD 17.97) |
| MACD | -0.25 (negative) |
From TRVI's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | USD 3.85 | ▲ 0% |
| XFOR | X4 Pharmaceuticals, Inc. | USD 4.04 | ▲ 0% |
| VRCA | Verrica Pharmaceuticals Inc. | USD 5.3 | ▼ 1.67% |
| STOK | Stoke Therapeutics, Inc. | USD 29.81 | ▼ 2.26% |
| TARA | Protara Therapeutics, Inc. | USD 3.94 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.